Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma

British Journal of Cancer

Volumn 88, Issue 2, 2003, Pages 251-256

  Rosenthal, A N ^a   Hopster, D ^a   Ryan, A ^a   Jacobs, I J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

HPV; LOH; P53; VIN; Vulval cancer

Indexed keywords

PROTEIN P53;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MUTATION; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VIRUS DETECTION; VULVA TUMOR; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; DNA, VIRAL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; VULVAR NEOPLASMS;

EID: 0037468097     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600677     Document Type: Article

References (33)

1. Arnold WJ, King CR, Magrina J, Masterson BJ (1980) Squamous cell carcinoma of the vulva and Fanconi anemia. Int J Gynaecol Obstet 18: 395-397
2. Beckmann AM, Acker R, Christiansen AE, Sherman KJ (1991) Human papillomavirus infection in women with multicentric squamous cell neoplasia. Am J Obstet Gynecol 165: 1431-1437
3. Dyson N, Howley PM, Munger K, Harlow E (1989) The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937
4. Emanuels AG, Koudstaal J, Burger MP, Hollema H (1999) In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases. Br J Cancer 80: 38-43
5. Flowers LC, Wistuba II, Scurry J, Muller CY, Ashfaq R, Miller DS, Minna JD, Gazdar AF (1999) Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas. J Soc Gynecol Invest 6: 213-221
6. Hejna JA, Timmers CD, Reifsteck C, Bruun DA, Lucas LW, Jakobs PM, Toth-Fejel S, Unsworth N, Clemens SL, Garcia DK, Naylor SL, Thayer MJ, Olson SB, Grompe M, Moses RE (2000) Localization of the Fanconi anemia complementation group D gene to a 200-kb region on chromosome 3p25.3. Am J Hum Genet 66: 1540-1551
7. Higgins GD, Uzelin DM, Phillips GE, Burrell CJ (1991) Presence and distribution of human papillomavirus sense and antisense RNA transcripts in genital cancers. J Gen Virol 72: 885-895
8. Hording U, Junge J, Daugaard S, Lundvall F, Poulsen H, Bock JE (1994) Vulvar squamous cell carcinoma and papillomaviruses: indications for two different etiologies. Gynecol Oncol 52: 241-246
9. Hording U, Junge J, Poulsen H, Lundvall F (1995) Vulvar intraepithelial neoplasia III: a viral disease of undetermined progressive potential. Gynecol Oncol 56: 276-279
10. Jochmus I, Durst M, Reid R, Altmann A, Bijward KE, Gissmann L, Jenson AB (1993) Major histocompatability complex and human papillomavirus type 16 E7 expression in high-grade vulvar lesions. Hum Pathol 24: 519-524
11. Kagie MJ, Kenter GG, Tollenaar RAEM, Hermans J, Trimbos JB, Fleuren GJ (1997a) p53 Protein overexpression, a frequent observation in squamous cell carcinoma of the vulva and in various synchronous vulvar epithelia, has no value as a prognostic parameter. Int J Gynecol Pathol 16: 124-130
12. Kagie M, Kenter GG, Tolenaar RAEM, Hermans J, Trimbos JB, Fleuren GJ (1997b) p53 Overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva. Cancer 80: 1228-1233
13. Kennedy AW, Hart WR (1982) Multiple squamous-cell carcinomas in Fanconi's anemia. Cancer 50: 811-814
14. Kim Y-T, Thomas NF, Kessis TD, Wilkinson EJ, Hedrick L, Cho KR (1996) p53 Mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus negative carcinomas. Hum Pathol 27: 389-395
15. Kohlberger P, Kainz C, Breitenecker G, Gitsch G, Sliutz G, Kolbl H, Tschachler E, Reinthaller A (1998) Absence of p53 protein over-expression in precancerous lesions of the vulva. Cancer 82: 323-327
16. Kurvinen K, Tervahauta A, Syrjanen S, Change F, Syrjanen K (1993) The state of the p53 gene in human papillomavirus (HPV)-positive and HPV-negative genital precancer lesions and carcinomas as determined by single-strand conformation polymorphism analysis and sequencing. Anticancer Res 14: 177-182
17. Lee YY, Wilczynski SP, Chumakov A, Chih D, Koeffler HP (1994) Carcinoma of the vulva: HPV and p53 mutations. Oncogene 9: 1655-1659
18. McConnell D, Miller ID, Parkin DE, Murray GI (1997) p-53 Protein expression in a population-based series of primary vulval squamous cell carcinoma and immediate adjacent field-change. Gynecol Oncol 67:248-254
19. Milde-Langosch K, Albrecht K, Joram S, Schlechte H, Giessing M, Loning T (1995) Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva. Int J Cancer 63: 639-645
20. Monk B, Burger RA, Lin F, Parkham G, Vasilev SA, Wilczynski SP (1995) Prognostic significance of human papillomavirus DNA in vulvar carcinoma. Obstet Gynecol 85: 709-715
21. Ngan HY, Cheung AN, Liu SS, Yip PS, Tsao SW (1999) Abnormal expression or mutation of TP53 and HPV in vulvar cancer. Eur J Cancer 35: 481-484
22. Park JS, Rader JS, Wu TC, Laimins LA, Currie JL, Kurman RJ, Shah KV (1991) HPV-16 viral transcripts in vulvar neoplasia: preliminary studies. Gynecol Oncol 42: 250-255
23. Pilotti S, D'Amato L, della Torre G, Donghi R, Longoni A, Giarola M, Sampietro G, de Palo G, Pierotti MA, Rilke F (1995) Papillomavirus, p53 alteration, and primary carcinoma of the vulva. Diagn Mol Pathol 4: 239-248
24. Pinto AP, Lin M-C, Mutter GL, Sun D, Villa LL, Crum CP (1999) Allelic loss in human papillomavirus-positive and -negative vulvar squamous cell carcinomas. Am J Pathol 154: 1009-1015
25. Rosenthal AN, Ryan A, Hopster D, Surentheran T, Jacobs II (2001) High frequency of loss of heterozygosity in vulval intraepithelial neoplasia (VIN) is associated with invasive vulval squamous cell carcinoma (VSCC). Int J Cancer 94: 896-900
26. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136
27. Scheistrøen M, Tropé C, Pettersen EO, Nesland JM (1999) p53 Protein expression in squamous cell carcinoma of the vulva. Cancer 85: 1133-1138
28. Scurry J, Hung J, Flowers L, Kneafsy P, Gazdar A (1999) Ploidy in human papillomavirus positive and negative vulvar squamous cell carcinomas and adjacent skin lesions. Int J Gynecol Cancer 9: 187-193
29. Sliutz G, Schmidt W, Tempfer C, Speiser P, Gitsch G, Elder S, Schneeberger C, Kainz C, Zeillinger R (1997) Detection of p53 point mutations in primary human vulvar cancer by PCR and temperature gradient gel electrophoresis. Gynecol Oncol 64: 93-98
30. Tervahauta AI, Syrjanen SM, Vayrnen M, Saastamoinen J, Syrjanen KJ (1993) Expression of p53 protein related to the presence of human papillomavirus (HPV) DNA in genital carcinomas and precancer lesions. Anticancer Res 13: 1107-1112
31. Van Beurden M, ten Kate FJW, Smits HL, Berkhout RJM, de Craen AJM, der Vange N, Lammes FB, ter Schegget J (1995) Multifocal vulvar intraepithelial neoplasia grade III and multicentric lower genital tract neoplasia is associated with transcriptionally active human papilloma-virus. Cancer 75: 2879-2884
32. Wilkinson EJ, Morgan LS, Friedrich Jr EG (1984) Association of Fanconi's anemia and squamous-cell carcinoma of the lower female genital tract with condyloma acuminatum. A report of two cases. J Reprod Med 29: 447-453
33. Wistube II, Lam S, Behrens C, Virmani AK, Fong KM, LeRiche J, Samet JM, Srivastava S, Minna JD, Gazdar AF (1997) Molecular damage in the bronchial epithelium of current and former smokers. J Natl Cancer Inst 89: 1366-1373